Research shows that semaglutide stored at 86 degrees Fahrenheit for just four weeks can lose up to 10 percent of its active ingredient

After 24 weeks, all groups taking retatrutide saw significant weight loss compared to the placebo group (1.6% average weight loss): 7.2% for those taking 1 mg 11.8% for those taking 4 mg after starting with 2 mg 13.9% for those taking 4 mg after starting with 4 mg 16.7% for those taking 8 mg after starting with 2 mg 17.9% for those taking 8 mg after starting with 4 mg 17.5% for those taking 12 mg after starting with 2 mg After 48 weeks, patients taking retatrutide experienced even more substantial losses: 8.7% for those taking 1 mg 16.3% for those taking 4 mg after starting with 2 mg 17.8% for those taking 4 mg after starting with 4 mg 21.7% for those taking 8 mg after starting with 2 mg 23.9% for those taking 8 mg after starting with 4 mg 24.2% for those taking 12 mg after starting with 2 mg The researchers also reported that 100% of patients taking 8 mg or 12 mg saw a weight reduction of at least 5%, and 7583% had a weight reduction of 15% or more

Treatment with GLP-1 analogs leads to symptomatic improvement in IBS patients (8, 10)
10.1016/j.surg.2009.02.024 Summary Keywords Insulin, diabetes mellitus, cancer metabolism, pancreatic ductal adenocarcinoma, hyperinsulinemia Citation Deng J, Guo Y, Du J, Gu J, Kong L, Tao B, Li J and Fu D (2022) The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular
The parallel is striking
doi 10.1093/ecco-jcc/jjae160 102 VillumsenMScheldeABJimenez-SolemEJessTAllinKH